Index.php

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to perform so could be grounds for compensation. Our lawyers are working hard to have these hurt by the drug the compensation they are entitled to.

Even though bleeding is actually a frequent complication related with anticoagulants, it has been alleged that Xarelto is much more hazardous than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, sufferers may possibly be at risk for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.

In case you or perhaps a Mahanmusicinst.Com loved one particular suffered a severe bleeding occasion right after taking Xarelto, you may have legal recourse. For much more details, get in touch with us right now to possess your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in situations of death, funeral expenditures. Moreover, they're seeking punitive damages, that are usually awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

Visit this page for far more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.